Marisa Joy Merritt, NP

Marisa Merritt practices at Scripps Clinic OB-GYN La Jolla Campus in La Jolla, California.

Marisa Merritt's NPI, 1720698970, was assigned on August 3, 2020. Marisa Merritt holds California license 95014428.

Marisa Merritt's primary practice is Scripps Clinic OB-GYN La Jolla Campus, at 9850 Genesee Ave, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 453-0753.

Marisa Merritt's primary practice is Scripps Clinic OB-GYN La Jolla Campus in La Jolla, California. The medical group on file is Perlman Clinic. Dmand AI also links Marisa Merritt to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Marisa Merritt practices. Vendor and product names are available with a free account.

Family is Marisa Merritt's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Marisa Merritt is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, asthma, bronchitis, chronic diabetes, fluid in a joint, hand joint or tendon inflammation and high cholesterol among the conditions Marisa Merritt treats.

CMS counts 11 Medicare patients who saw Marisa Merritt in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Marisa Merritt's median patient age at 50, with 80% women.

In 2024, Marisa Merritt wrote 537 Medicare Part D claims for 107 patients. 90% of them were for generic drugs. CMS names the drug for 238 of them, across 12 drugs with 11 or more claims each, at $12,841 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Marisa Merritt for performance year 2024, reported as part of a group. Marisa Merritt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Marisa Merritt as offering telehealth.

CMS Open Payments shows 11 general payments to Marisa Merritt from 6 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Organon LLC paid the most, $142.